Your browser doesn't support javascript.
loading
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study.
Musolino, A; Falcini, F; Sikokis, A; Boggiani, D; Rimanti, A; Pellegrino, B; Silini, E M; Campanini, N; Barbieri, E; Zamagni, C; Degli Esposti, R; Cortesi, L; Bisagni, G; Cavanna, L; Frassoldati, A; Sgargi, P; Michiara, M.
Afiliação
  • Musolino A; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy. Electronic address: antoninomusolino@hotmail.com.
  • Falcini F; Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Forlì, Italy; Azienda USL Della Romagna, Forlì, Italy.
  • Sikokis A; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy.
  • Boggiani D; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy.
  • Rimanti A; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy.
  • Pellegrino B; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy.
  • Silini EM; Section of Anatomy and Pathology, University Hospital of Parma, Italy.
  • Campanini N; Section of Anatomy and Pathology, University Hospital of Parma, Italy.
  • Barbieri E; SSD Oncologia Medica Addarii, Policlinico S.Orsola-Malpighi, Bologna, Italy.
  • Zamagni C; SSD Oncologia Medica Addarii, Policlinico S.Orsola-Malpighi, Bologna, Italy.
  • Degli Esposti R; Medical Oncology Unit, Azienda USL-IRCCS Scienze Neurologiche, Bologna, Italy.
  • Cortesi L; Department of Oncology, Hematology and Respiratory Diseases, University Hospital of Modena, Italy.
  • Bisagni G; Department of Oncology and Advanced Technologies, Oncology Unit, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Cavanna L; Department of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy.
  • Frassoldati A; Division of Medical Oncology, University Hospital of Ferrara, Italy.
  • Sgargi P; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy.
  • Michiara M; Medical Oncology Unit and Cancer Registry of Parma Province, University Hospital of Parma, Italy.
Eur J Cancer ; 88: 10-20, 2018 01.
Article em En | MEDLINE | ID: mdl-29175735
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sistema de Registros / Vigilância da População / Receptor ErbB-2 / Detecção Precoce de Câncer Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sistema de Registros / Vigilância da População / Receptor ErbB-2 / Detecção Precoce de Câncer Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article